Zai Lab (ZLAB) Gains from Investment Securities (2018 - 2026)
Zai Lab recorded quarterly Gains from Investment Securities of $78000.0 in Q1 2026, up 114.39% quarter-over-quarter from -$542000.0 in Q4 2025, and up 105.57% year-over-year from $37943.8 in Q1 2025.
Zai Lab's Gains from Investment Securities history runs 9 years deep, the most recent figure standing at $78000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 105.57% year-over-year to $78000.0; the TTM figure through Mar 2026 stood at $937000.0 (up 144.09% YoY), while the FY2025 annual figure was -$542000.0, down 19.65% from the prior year.
- Gains from Investment Securities came in at $78000.0 for Q1 2026 at Zai Lab, up from -$542000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $7.2 million in Q2 2023 to a low of -$8.9 million in Q4 2023.
- A 5-year average of -$97882.4 and a median of $51000.0 in 2025 frame the typical range for Gains from Investment Securities.
- On a YoY basis, Gains from Investment Securities climbed as much as 115000.0% in 2022 and fell as far as 10566.67% in 2022.
- Zai Lab's Gains from Investment Securities stood at -$7.7 million in 2022, then dropped by 15.28% to -$8.9 million in 2023, then jumped by 50.65% to -$4.4 million in 2024, then surged by 87.68% to -$542000.0 in 2025, then surged by 114.39% to $78000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $78000.0, -$542000.0, and $51000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Zai Lab | 19.59 Bn | 19.49 Bn | 61.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | -542,000.00 |
| Dec 31, 2025 | -542,000.00 |
| Sep 30, 2025 | 51,000.00 |
| Sep 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | -1.40 Mn |
| Mar 31, 2025 | -1.40 Mn |
| Dec 31, 2024 | -4.40 Mn |
| Dec 31, 2024 | -4.40 Mn |
| Sep 30, 2024 | 3.71 Mn |
| Sep 30, 2024 | 3.71 Mn |
| Jun 30, 2024 | -39,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Mar 31, 2024 | 271,000.00 |
| Mar 31, 2024 | 271,000.00 |
| Dec 31, 2023 | -8.91 Mn |
| Dec 31, 2023 | -8.91 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 7.21 Mn |
| Jun 30, 2023 | 7.21 Mn |
| Mar 31, 2023 | -64,000.00 |
| Mar 31, 2023 | -64,000.00 |
| Dec 31, 2022 | -7.73 Mn |
| Dec 31, 2022 | -7.73 Mn |
| Sep 30, 2022 | -1.28 Mn |
| Sep 30, 2022 | -1.28 Mn |
| Jun 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 3.86 Mn |
| Mar 31, 2022 | 4.60 Mn |
| Mar 31, 2022 | 4.60 Mn |
| Dec 31, 2021 | 4.27 Mn |
| Dec 31, 2021 | 4.27 Mn |
| Sep 30, 2021 | -12,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Mar 31, 2021 | -4,000.00 |
| Mar 31, 2021 | -4,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2019 | -24,396.00 |
| Dec 31, 2019 | -24,396.00 |
| Sep 30, 2019 | -604.00 |
| Sep 30, 2019 | -604.00 |
| Dec 31, 2018 | -1,704.00 |
| Dec 31, 2018 | -1,704.00 |